PlainRecalls
FDA Drug Moderate Class II Terminated

Formula 9 (Papaverine 0.9 mg, Phentolamine 0.1 mg, Atropine 0.01 mg, PGE 20 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.

Reported: April 13, 2016 Initiated: March 14, 2016 #D-0804-2016

Product Description

Formula 9 (Papaverine 0.9 mg, Phentolamine 0.1 mg, Atropine 0.01 mg, PGE 20 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.

Reason for Recall

Lack of Assurance of Sterility: incomplete or missing data regarding production.

Details

Units Affected
1320 vials - all formulas
Distribution
Nationwide
Location
Las Vegas, NV

Frequently Asked Questions

What product was recalled?
Formula 9 (Papaverine 0.9 mg, Phentolamine 0.1 mg, Atropine 0.01 mg, PGE 20 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.. Recalled by Meditech Laboratories, Inc. Units affected: 1320 vials - all formulas.
Why was this product recalled?
Lack of Assurance of Sterility: incomplete or missing data regarding production.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 13, 2016. Severity: Moderate. Recall number: D-0804-2016.